Polyrizon Ltd. (NASDAQ:PLRZ) Short Interest Down 21.8% in February

Polyrizon Ltd. (NASDAQ:PLRZ) was the recipient of a significant drop in short interest in February. As of February 27th, there was short interest totaling 42,068 shares, a drop of 21.8% from the February 12th total of 53,763 shares. Based on an average daily volume of 32,456 shares, the days-to-cover ratio is presently 1.3 days. Currently, 4.0% of the shares of the stock are sold short. Currently, 4.0% of the shares of the stock are sold short. Based on an average daily volume of 32,456 shares, the days-to-cover ratio is presently 1.3 days.

Hedge Funds Weigh In On Polyrizon

An institutional investor recently bought a new position in Polyrizon stock. Jane Street Group LLC purchased a new stake in shares of Polyrizon Ltd. (NASDAQ:PLRZ) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor purchased 14,032 shares of the company’s stock, valued at approximately $119,000. Jane Street Group LLC owned about 1.35% of Polyrizon at the end of the most recent quarter.

Analysts Set New Price Targets

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Polyrizon in a research note on Thursday, January 22nd. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, the company presently has a consensus rating of “Sell”.

Polyrizon Trading Down 6.5%

PLRZ traded down $0.99 on Friday, hitting $14.30. The company had a trading volume of 47,825 shares, compared to its average volume of 33,099. The business’s fifty day simple moving average is $13.85 and its 200 day simple moving average is $9.36. Polyrizon has a 12-month low of $2.88 and a 12-month high of $2,235.00.

Polyrizon Company Profile

Polyrizon Ltd. is a development stage biotech company specializing in the development of medical device hydrogels delivered in the form of nasal sprays. Polyrizon Ltd. is based in Raanana, Israel.